A Risk-Assessing Signature Based on Hypoxia- and Immune-Related Genes for Prognosis of Lung Adenocarcinoma Patients.

Wang Y, Feng J, Liu Y, Han T

Open source

DOI
10.1155/2022/7165851
Published
2022
Container
Computational and mathematical methods in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/7165851,
  title = {A Risk-Assessing Signature Based on Hypoxia- and Immune-Related Genes for Prognosis of Lung Adenocarcinoma Patients.},
  author = {Wang Y and Feng J and Liu Y and Han T},
  year = {2022},
  journal = {Computational and mathematical methods in medicine},
  doi = {10.1155/2022/7165851},
  url = {https://doi.org/10.1155/2022/7165851}
}

RIS

TY  - JOUR
TI  - A Risk-Assessing Signature Based on Hypoxia- and Immune-Related Genes for Prognosis of Lung Adenocarcinoma Patients.
AU  - Wang Y
AU  - Feng J
AU  - Liu Y
AU  - Han T
PY  - 2022
JO  - Computational and mathematical methods in medicine
DO  - 10.1155/2022/7165851
UR  - https://doi.org/10.1155/2022/7165851
ER  - 

APA

Y, W., J, F., Y, L., & T, H. (2022). A Risk-Assessing Signature Based on Hypoxia- and Immune-Related Genes for Prognosis of Lung Adenocarcinoma Patients.. Computational and mathematical methods in medicine. https://doi.org/10.1155/2022/7165851

Source records